Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Pancreatic Neoplasms × Leucovorin × Clear all

Phase

Phase 2 49 Phase 1 22 Phase 3 18 Phase 1/2 17 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9 Stomach Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 4 Rectal Neoplasms 3 Neoplasms 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Biliary Tract Neoplasms 2 Vipoma 1 Somatostatinoma 1 Resected Liver Metastases From Colorectal Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neutropenia 1 Neuroendocrine Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1 Insulinoma 1 Glucagonoma 1 Gestational Trophoblastic Disease 1 Gastrinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Islet Cell 1 Adenoma, Islet Cell 1

Interventions

Gemcitabine 12 Fluorouracil 5 Cisplatin 4 Irinotecan 3 Capecitabine 3 nimotuzumab 2 Taxes 2 Phytotherapy 2 Oxaliplatin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 surufatinib 1 rubitecan 1 racemetyrosine 1 methylnaltrexone 1 folfirinox 1 camrelizumab 1 Tranexamic Acid 1 Standard of Care 1 Sirolimus 1 Positron Emission Tomography Computed Tomography 1 Phenytoin 1 Paclitaxel 1 Neoadjuvant Therapy 1 NUC-1031 1 Mirtazapine 1 Methoxsalen 1 Magnetic Resonance Spectroscopy 1 Levobupivacaine 1 Leucovorin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00785421 2015-01-08

PROSPECT

CONKO-Studiengruppe

Phase 2/3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡